ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ESYN vs MEDS // ENTERPRISE SCALE & MARKET CAP

EnerSyn Global Inc. (NASDAQ) VS. DataMeds AI Inc. (NASDAQ) • 15-METRIC TALLY: ESYN 4 — MEDS 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ESYN
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESYN VS. MEDS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ESYN MEDS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 53.00% -27.50% +80.50 ESYN /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.25% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -30.80% 28.70% -59.50 MEDS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 ESYN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.6 38.9 +3.67 ESYN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $54.4M $9.8M $44.6M ESYN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ESYN REV MEDS REV ESYN GROSS % MEDS GROSS % ESYN FCF MEDS FCF
FY 2025 $866.9K $23.3M 53.0% -27.5% -$1.8M -$10.9M
FY 2024 $1.3M $18.1M 48.0% 9.7% -$1.8M -$1.2M
FY 2023 $1.2K $0 — — -$2.6M -$349.1K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESYN // BETA —
MEDS // BETA —